Antitrust & Trade Regulation, Mergers & Acquisitions, Science, Computers & Technology

FTC Report Shows that Oil Sector and Pharmaceutical Sector Mergers Are Under the Antitrust Spotlight

by MIke Cowie, Michael Weiner | Dechert LLP on 1/23/2013

The U.S. Federal Trade Commission (“FTC”) issued a data report on January 4 regarding its horizontal merger investigation and enforcement action record over the past fifteen years. The report shows, sector by-sector, the...more

FTC and DOJ Explore Role of Patent Assertion Entities in the Patent Innovation Market

by John L. Cooper, Stephanie Skaff | Farella Braun + Martel LLP on 12/21/2012

On December 10, 2012, the Federal Trade Commission (FTC) and the Department of Justice (DOJ) jointly presented the “Patent Assertion Entities (PAEs) Activities Workshop.” This publicly-held workshop signaled a recognition by...more

Unfiltered Orange | Weekly eDiscovery News Update – November 14, 2012

by Rob Robinson on 11/14/2012

Highlighted in Forbes’ Law & Technology Blog as one of Eight Great Law & Technology Resources, Orange Legal Technologies’ Unfiltered Orange Weekly eDiscovery News Updates provide readers with a trusted compilation of key...more

Health Care Legal News - October 25, 2012 • Volume 2, Number 9

by Dickinson Wright on 10/30/2012

In This Issue: - Five Core antitrust Principles For mergers of health insurers By: James M. Burns. On July 9, WellPoint and Amerigroup, two prominent health insurers, announced that they intended to merge in a...more

Unfiltered Orange | Weekly eDiscovery News Update – October 24, 2012

by Rob Robinson on 10/24/2012

Highlighted in Forbes’ Law & Technology Blog as one of Eight Great Law & Technology Resources, Orange Legal Technologies’ Unfiltered Orange Weekly eDiscovery News Updates provide readers with a trusted compilation of key...more

New FTC/DOJ Position Will Require Heightened Regulatory Reporting of Pharma, Biological and Diagnostic Licenses -- October 25,...

by Loeb & Loeb LLP on 10/3/2012

The Federal Trade Commission and Department of Justice recently announced revisions to the Hart-Scott-Rodino (HSR) Act’s premerger notification rules to require enhanced reporting of transactions (including licenses) relating...more

FTC proposes framework for the transfer of patent rights in the pharmaceutical industry

by Saul Ewing LLP on 10/2/2012

The FTC has proposed amendments to the premerger notification Rules to codify prior FTC guidance concerning when a transaction involving the transfer of rights to a patent in the pharmaceutical and medicine manufacturing...more

FTC Seeks Comments on Proposed HSR Rule Amendments Related to the Transfer of Exclusive Patent Rights in the Pharmaceutical...

by Perkins Coie on 9/10/2012

The Federal Trade Commission (“FTC”) recently announced and asked for comments on proposed changes to the premerger notification rules under the Hart-Scott-Rodino Act (“HSR Act”). The proposed rules would require...more

FTC Sights Set on Pharma Deals – Calls for Additional Hart-Scott-Rodino Reporting

by Proskauer Rose LLP on 8/29/2012

The Federal Trade Commission has proposed expanding Hart-Scott-Rodino reporting and waiting period obligations for certain pharmaceutical, biologics and medicine manufacturing licenses. The new rules are subject to public...more

FTC Flexes Healthcare Regulatory Muscle

by Morgan Lewis on 8/23/2012

Proposed rule includes new requirements for reporting pharmaceutical patent transfers. On August 13, the Federal Trade Commission (FTC) released proposed amendments to the premerger notification rules (the Proposed...more

Unfiltered Orange | Weekly eDiscovery News Update – August 22, 2012

by Rob Robinson on 8/22/2012

Highlighted in Forbes’ Law & Technology Blog as one of Eight Great Law & Technology Resources, Orange Legal Technologies’ Unfiltered Orange Weekly eDiscovery News Updates provide readers with a trusted compilation of key...more

Yet Another Turn of the Screw: The FTC Again Targets Pharmaceutical Industry, This Time Through the HSR Act

by K&L Gates LLP on 8/21/2012

Fresh from its victory in the Third Circuit on “pay-for-delay” deals involving brand name and generic pharmaceutical companies, the Federal Trade Commission (“FTC”) has announced yet another initiative aimed at the...more

FTC Proposes Amendments to HSR Rules Targeting Certain Pharmaceutical Licensing Arrangements

by Mintz Levin - Antitrust on 8/17/2012

The Federal Trade Commission (FTC) recently announced proposed amendments to the Premerger Notification Rules (HSR Rules) to clarify reporting requirements under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as...more

FTC’s Proposed Rules Would Generate More HSR Filings for Transfers of Pharmaceutical Patent Rights

by McDermott Will & Emery on 8/17/2012

The U.S. Federal Trade Commission’s new proposed Hart-Scott-Rodino Act rules will apply only to transfers of pharmaceutical patent rights and are expected to increase the number of filings. Comments on the proposed rules will...more

FTC Proposes Amendments to the Premerger Notification Rules to Expand the Reportability of Transfers of Exclusive Patent Rights in...

by Sheppard Mullin Richter & Hampton LLP on 8/16/2012

On August 13, 2012, the Federal Trade Commission (“FTC”) proposed amendments to the Premerger Notification Rules issued under the Hart Scott Rodino Antitrust Improvements Act of 1976 (the “HSR Act”). The proposed amendments...more

FTC Proposes New HSR Rules for Exclusive Patent Licenses in the Pharmaceutical Industry

by Duane Morris LLP on 8/15/2012

On August 13, 2012, the U.S. Federal Trade Commission (FTC) announced it is seeking public comment to proposed changes to the premerger notification rules under the Hart Scott Rodino Act (HSR) relating to acquisitions of...more

FTC Proposes Changes to HSR Reportability of Patent Licenses

by Ropes & Gray LLP on 8/15/2012

The Federal Trade Commission has announced proposed rule changes that will impact the reportability of pharmaceutical patent licenses under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR Act”). If the rules...more

FTC May Expand Premerger Reporting Requirements to Include Pharmaceutical Patent Exclusive Marketing and Sales Licenses

by Howard Ullman on 8/15/2012

Earlier this week, the FTC (in cooperation with the DOJ) announced that it is considering making changes to the premerger notification rules that would require pharmaceutical companies to make Hart-Scott-Rodino (HSR) filings...more

China's MOFCOM Grapples With Open Source Issues In Google-Motorola Deal

by Sheppard Mullin Richter & Hampton LLP on 6/1/2012

This past February the US Department of Justice (“DOJ”) and European Commission (“Commission”) cleared Google Inc.’s acquisition of Motorola Mobility Holdings Inc. without any conditions. In contrast, on May 19, 2012 the...more

China Conditionally Clears Western Digital’s Acquisition of Hitachi’s Hard Disk Drive Business

by McDermott Will & Emery on 3/16/2012

Recently China’s Ministry of Commerce (MOFCOM) approved Western Digital’s proposed acquisition of Hitachi’s hard disk drive business on a conditional basis. Containing the most comprehensive clearance conditions ever imposed...more

DOJ to Standard Essential Patent Holders—“We have our eye on you”

by Bradley Arant Boult Cummings LLP on 2/22/2012

Last week, the Antitrust Division of the Department of Justice warned patent holders to make sure that enforcement of their patent rights do not hinder competition, either by charging excessive royalties or by foreclosing...more

Monopolization Claims Against Adobe Relating to Acquisition of FreeHand Survive Motion to Dismiss

by Howard Ullman on 2/15/2012

Judge Koh refused to dismiss the bulk of an antitrust complaint Against Adobe Systems relating to its acquisition of FreeHand, a professional vector graphic illustration software. Although Adobe signed an FTC consent...more

Taiwan Antitrust Newsletter Q1 2012

by Victor I-Hsiu Chang on 2/1/2012

LCS & Partners is a leading full-service law firm in Taiwan and the Greater China Region. LCS & Partners has been preeminent in representing domestic and foreign clients in all areas of competition law in Taiwan. We have...more

New Seventh Circuit Decision Endorses Heightened Scrutiny of Experts at Class Certification Stage While Potentially Lowering the...

by Mintz Levin - Antitrust on 1/27/2012

In the health care antitrust world, the Federal Trade Commission (FTC) Evanston case, involving a retrospective attack on the consummated merger between Evanston Northwestern and Highland Park hospitals, is an important...more

MoFo Tech magazine

by J. David Harvey on 11/10/2011

MoFo Tech is at the intersection of tech trends and legal issues. Here is our latest including information, trend-spotting and analysis for science and tech-based companies....more

Home

Legal News

Find a Lawyer

Browse Subjects

Subscribe

Pro Services

For Reporters

Antitrust & Trade Regulation › Mergers & Acquisitions › Science, Computers & Technology

FTC Report Shows that Oil Sector and Pharmaceutical Sector Mergers Are Under the Antitrust Spotlight

FTC and DOJ Explore Role of Patent Assertion Entities in the Patent Innovation Market

Unfiltered Orange | Weekly eDiscovery News Update – November 14, 2012

Health Care Legal News - October 25, 2012 • Volume 2, Number 9

Unfiltered Orange | Weekly eDiscovery News Update – October 24, 2012

New FTC/DOJ Position Will Require Heightened Regulatory Reporting of Pharma, Biological and Diagnostic Licenses -- October 25,...

FTC proposes framework for the transfer of patent rights in the pharmaceutical industry

FTC Seeks Comments on Proposed HSR Rule Amendments Related to the Transfer of Exclusive Patent Rights in the Pharmaceutical...

FTC Sights Set on Pharma Deals – Calls for Additional Hart-Scott-Rodino Reporting

FTC Flexes Healthcare Regulatory Muscle

Unfiltered Orange | Weekly eDiscovery News Update – August 22, 2012

Yet Another Turn of the Screw: The FTC Again Targets Pharmaceutical Industry, This Time Through the HSR Act

FTC Proposes Amendments to HSR Rules Targeting Certain Pharmaceutical Licensing Arrangements

FTC’s Proposed Rules Would Generate More HSR Filings for Transfers of Pharmaceutical Patent Rights

FTC Proposes Amendments to the Premerger Notification Rules to Expand the Reportability of Transfers of Exclusive Patent Rights in...

FTC Proposes New HSR Rules for Exclusive Patent Licenses in the Pharmaceutical Industry

FTC Proposes Changes to HSR Reportability of Patent Licenses

FTC May Expand Premerger Reporting Requirements to Include Pharmaceutical Patent Exclusive Marketing and Sales Licenses

China's MOFCOM Grapples With Open Source Issues In Google-Motorola Deal

China Conditionally Clears Western Digital’s Acquisition of Hitachi’s Hard Disk Drive Business

DOJ to Standard Essential Patent Holders—“We have our eye on you”

Monopolization Claims Against Adobe Relating to Acquisition of FreeHand Survive Motion to Dismiss

Taiwan Antitrust Newsletter Q1 2012

New Seventh Circuit Decision Endorses Heightened Scrutiny of Experts at Class Certification Stage While Potentially Lowering the...

MoFo Tech magazine

Expand Your Reach